ArticleLeukemia & lymphoma2019

Managing patients with ibrutinib-resistant CLL: don't stop ibrutinib until you are ready with the next therapy.

Pek Sang Chloe Tang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.